Asymmetry Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,980	Closed	-$5.94M	–	29
2019 Q2	$5.94M	Buy	4,980 +3,610	+264%	+$4.3M	3.21%	13
2019 Q1	$1.71M	Buy	+1,370	New	+$1.71M	2.85%	12